İnsan kronik miyeloid lösemi K562 hücrelerinde karbakolün apoptoza etkisi

Amaç: Muskarinik reseptörler merkezi sinir sisteminde

Effects of carbachol on apoptosis in human chronic myelogenous leukemic K562 cell line

Objectives: Muscarinic receptors mediate diverse actions of

___

  • 1. Pierce KL, Premont RT, Lefkowitz RJ. Seven transmembrane receptors. Nat Rev Mol Cell Biol 2002;3:639-50. doi: 10.1038/nrm908
  • 2. Haga T. Molecular properties of muscarinic acetylcholine receptors. Proc Jpn Acad Ser B Phys Biol Sci 2013;89:226- 56. doi: 10.2183/pjab.89.226
  • 3. Gutkind JS, Novotny EA, Brann MR, Robbins KC. Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc Natl Acad Sci USA 1991;88:4703– 07.
  • 4. Rayford W, Noble MJ, Austenfeld MA, Weigel J, Mebust WK, Shah GV. Muscarinic cholinergic receptors promote growth of human prostate cancer cells. Prostate 1997; 30:160-6. doi: 10.1002/(SICI)1097-0045(19970215)30:3<160::AID – PROS3>3.0.CO;2-Q
  • 5. Luthin GR, Wang P, Zhou H, Dhanasekaran D, Ruggieri MR. Role of m1 receptor-G protein coupling in cell proliferation in the prostate. Life Sci 1997;60:963-8. doi: 10.1016/S0024- 3205(97)00035-0
  • 6. Wang L, Jiang R, Song SD, Hua ZS, Wang JW, Wang YP. Angelica sinensis polysaccharide induces erythroid differentiation of human chronic myelogenous leukemia k562 cells. Asian Pac J Cancer Prev 2015;16:3715-21.
  • 7. Taverna S, Giallombardo M, Pucci M, et al. Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21. Oncotarget 2015;6:21918-33. doi: 10.18632/ oncotarget.4204
  • 8. Klein E, Ben-Bassat H, Neumann H, et al. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Can 1976;18:421-31. doi: 10.1002/ ijc.291.018.0405
  • 9. Cabadak H, Aydin B, Kan B. Regulation of M2, M3, and M4 muscarinic receptor expression in K562 chronic myelogenous leukemic cells by carbachol. J Recept Signal Transd Res 2011;31:26-32. doi: 10.3109/10799.893.2010.506484
  • 10. Fleisher TA. Apoptosis. Ann Allergy Asthma Immunol 1997;78:245-9. doi: 10.1016/S1081-1206(10)63176-6
  • 11. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998; 281:1305-8. doi: 10.1126/ science.281.5381.1305
  • 12. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12. doi: 10.1126/science.281.5381.1309
  • 13. Hughes D, Mehmet H. Cell proliferation and apoptosis. Advanced Methods. Oxford: Bios Scientific Publishers Limited, 2003.
  • 14. Wyllie AH, Moms RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984;142: 67. doi: 10.1002/path.171.142.0112.
  • 15. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306.
  • 16. Rosenblum K, Futter M, Jones M, E. Hulme C, Bliss T V P, “ERKI/II regulation by the muscarinic acetylcholine receptors in neurons,” J Neurosci 2000;20:977-85. doi: 10.1523/JNEUROSCI.20-03-00977.2000
  • 17. Yu H, Xia H, Tang Q, et al. Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation. Sci Rep 2017;7:40802. doi: 10.1038/srep40802
  • 18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
  • 19. Aydın B, Kan B, Cabadak H. The role of intracellular pathways in the proliferation of human K562 cells that is mediated by muscarinic receptors. Leukemia Res 2013;37: 1144-9. doi: 10.1016/j.leukres.2013.05.018
  • 20. Schuller HM. Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosamines. Biochem Pharmacol 1989;38:3439-42. doi: 10.1016/0006- 2952(89)90112-3
  • 21. Maneckjee R, Minna JD. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci USA 1990;87:3294-8. doi: 10.1073/pnas.87.9.3294.
  • 22. Cheng K, Zimniak P, Raufman JP. Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells. Cancer Res 2003;63:6744–50.
  • 23. Shant J, Cheng K, Marasa BS, Wang JY, Raufman JP. Aktdependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis. Exp Cell Res 2009;315:432-50. doi: 10.1016/j.yexcr.2008.11.003
  • 24. Peng Z, Heath J, Drachenberg C, Raufman JP, Xie G. Cholinergic muscarinic receptor activation augments murine intestinal epithelial cell proliferation and tumorigenesis. BMC Cancer 2013;13:204. doi: 10.1186/1471-2407-13-204
  • 25. Raufman JP, Shant J, Xie G, et al. Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice. Carcinogenesis 2011;32:1396-402. doi: 10.1093/ carcin/bgr118
  • 26. Raufman JP, Samimi R, Shah N,et al. Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia. Cancer Res 2008;68:3573-8. doi: 10.1158/0008-5472.CAN-07-6810
  • 27. Cheng K, Shang AC, Drachenberg CB, Zhan M, Raufman J P. Differential expression of M3 muscarinic receptors in progressive colon neoplasia and metastasis. Oncotarget 2017;8: 21106-14. doi: 10.18632/oncotarget.15500
  • 28. Cabadak H, Kücükibrahimoğlu E, Aydin B, Kan B, Gören MZ. Muscarinic receptor- mediated nitric oxide release in a K562 erythroleukaemia cell line. Auton Autacoid Pharmacol 2009;29:109-15. doi: 10.1111/j.1474-8673.2009.00431.x
  • 29. Cabadak H, Aydin B, Kan B. Muscarinic receptor mediated cAMP response in human K562 chronic myelogenous leukemia cells. Turk J Biochem 2011;36:18-92.
  • 30. Kodaira M, Kajimura M, Takeuchi K, Lin S, Hanai H, Kaneko E. Functional muscarinic m3 receptor expressed in gastric cancer cells stimulates tyrosine phosphorylation and MAP kinase. J Gastroenterol 1999;34: 163-71. doi: 10.1007/ s005.350.050238
  • 31. Fujii T, Tsuchiya T, Yamada S, et al. Localization and synthesis of acetylcholine in human leukemic T cell lines. J Neurosci Res 1996;44:66-72. doi: 10.1002/(SICI)1097- 4547(19960401)44:1<66::AID-JNR9>3.0.CO;2-G
  • 32. Kawashima K, Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 2000;86:29-48. doi: 10.1016/ S0163-7258(99)00071-6.
  • 33. Shah N, Khurana S, Cheng K, Raufman JP. Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol 2009;296:C221-32. doi: 10.1152/ajpcell.00514.2008
  • 34. Guizetti M, Moore NH, Van DeMark KL, Giordano G, Costa LG. Muscarinic receptor-activated signal transduction pathways involved in the neuritogenic effect of astrocytes in hippocampal neurons. Eur J Pharmacol 2011;659:102-7. doi: 10.1016/j.ejphar.2011.03.019
Marmara Medical Journal-Cover
  • ISSN: 1019-1941
  • Yayın Aralığı: Yılda 3 Sayı
  • Başlangıç: 1988
  • Yayıncı: Marmara Üniversitesi
Sayıdaki Diğer Makaleler

Kitle oluşturarak Hodgkin lenfomayı taklit eden ekstramedüller hematopoez olgusu

Faruk Erdem KOMBAK, Süheyla Uyar BOZKURT, Toluy ÖZGÜMÜŞ, Işık Kaygusuz ATAGÜNDÜZ

Polikistik over sendromunda insülin rezistansı ve nöropeptid Y düzeyleri arasındaki ilişkinin araştırılması

Tolga KÖŞECİ, Ömer Ensar KAYA, Veysel HAKSÖYLER, Didem DERİCİ YILDIRIM, Kerem SEZER

Beyaz önlük hipertansiyonunda uç organ hasarı ile vücut kitle indeksi arasındaki ilişki

Atakan DEMİR, Mevlüt Tamer DİNÇER

Yüksek yağlı diyetle indüklenmiş obez sıçanların bozulmuş epididimal sperm parametreleri üzerine egzersizin iyileştirici etkisi

Merve ELMAS AÇIKEL, Feriha ERCAN, Serap ARBAK

Non-alkolik steatohepatite bağlı sirozda komplikasyonların ve mortalitenin değerlendirilmesi

Sezgin VATANSEVER, Zehra Betül PAKÖZ

İnsan kronik miyeloid lösemi K562 hücrelerinde karbakolün apoptoza etkisi

Marmara Üniversitesi Tıp Fakültesi Biyofizik Anabilim Dalı Maltepe İstanbul TÜRKİYE, Aysın TULUNAY, Ekşioğlu Emel DEMİRALP, Beki KAN, Hülya CABADAK

Kolinerjik bileşiklerin ve TNF-alfanın insan eritrolösemi K562 hücre çoğalmasına ve kaspaz ekspresyonu üzerine etkileri

Zehra KANLI, Banu Küçükemre AYDIN, Hülya CABADAK

Erişkin herediter anjiödem hastalarında danazol ile yapılan uzun dönem profilaksi tedavisine uyumun değerlendirilmesi: Gerçek bir yaşam çalışması

Semra TİRYAKİ DEMİR, Derya ÜNAL, Müge OLGAÇ, Aslı GELİNCİK, Raif COŞKUN, Bahauddin ÇOLAKOĞLU, Suna BÜYÜKÖZTÜRK

Metastatik tiroid kanserinde sistemik tedavi etkinliğinin retrospektif olarak değerlendirilmesi

Atakan DEMİR

Deneysel parsiyel splenektomi modelinde sıçanlarda algan hemostatik ajanın kanama kontrolünde etkinliğinin araştırılması

Ahmet MİDİ, Hüsamettin EKİCİ, ALİ KUMANDAŞ, Ömercan DURMUŞ, Buse BODİÇ, Mehmet Zahit TİRYAKİ, Mehmet Sabri BALIK, Erdem YEŞİLADA